FMO5 and cardiac arrhythmia: Regarding the pathogenesis of anthracycline-associated arrhythmias, Carmine Rocca et al. proposed that excessive reactive oxygen species (ROS) generation during anthracycline drug metabolism can inhibit the function of cardiac antioxidant enzymes, such as mitochondrial enzymes and NADPH oxidase.